Empagliflozin vs Imatinib

## Empagliflozin vs Imatinib: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Imatinib**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Imatinib — 18 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Imatinib — C29H31N7O.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Imatinib — 493.6030 g/mol.

**Type**: Empagliflozin — Small molecule; Imatinib — Small molecule.